MCKESSON USES IBM TECHNOLOGY
McKesson is using new analytics technologies made in IBM Labs to reduce CO2 and improve pharmaceutical distribution. (PRNewsFoto/IBM)PRNewsFoto/IBM
  • Previous Rank
    5
  • Revenues ($M)
    192487
  • Revenue Percent Change
    6.2
  • Profits ($M)
    2258
  • Profits Percent Change
    53
  • Assets ($M)
    56563
  • Employees
    68000
  • Market Value — as of March 31, 2017 ($M)
    31439

McKesson, the largest U.S. pharmaceutical distributor, continues to face obstacles as the tailwind from branded drug price inflation subsides and customers look elsewhere. But its management isn't taking the news lying down. A series of acquisitions, ongoing restructuring, and a rash of new deals are helping lessen the blow, setting in motion a roller-coaster ride of a year. McKesson was founded in 1833 and is headquartered in San Francisco.

Company Info

CEOJohn H. Hammergren
CEO TitleChairman, President & Chief Executive Officer
SectorWholesalers
IndustryWholesalers: Health Care
HQ LocationSan Francisco, CA
Websitewww.mckesson.com
Years on Fortune 500 List23
Employees68,000

Key Financials (Last Fiscal Year)

Revenues ($M)$192,487
Profits ($M)$2,258
Assets ($M)$56,563
Total Stockholder Equity ($M)$8,924
Market Value — as of March 31, 2017 ($M)$31,439

Profit Ratios

Profit as % of Revenues1.2%
Profits as % of Assets4%
Profits as % of Stockholder Equity25.3%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)10
EPS % Change (from 2015)54.7%
EPS % Change (5 year annual rate)16.2%
EPS % Change (10 year annual rate)15.1%

Total Return

Total Return to Investors (2016)-28.3%
Total Return to Investors (5 year, annualized)13.3%
Total Return to Investors (10 year, annualized)11.6%